Pasta maker Barilla funds cell therapy research for coronavirus
The Barilla family, which owns the pasta maker of the same name, has donated $500,000 to U.S. non-profit association “The Cure Alliance” to fund research on a COVID-19 therapy based on stem cells, the group said on Monday.
The clinical trial for the cure, which is being developed by a group of international scientists led by Italian professor Camillo Ricordi, has already received approval from the U.S. Food and Drug Administration, Barilla said.
A 24-patient clinical trial will be carried out in Miami to assess the efficacy of the therapy aimed at blocking the life-threatening lung inflammation that accompanies severe cases of the disease triggered by the coronavirus.
The money adds to a previous 2 million euro ($2.19 million) donation made last month by the company to health institutions in Italy to fight the coronavirus outbreak in the company’s home country.
Reuters
Related news
Consumer confidence in branded products is growing again in Germany
The popularity of private label products has somewhat waned and…
Read more >K&H: many people still don’t look around for the mandatory ones
Although the majority of middle-aged car owners are open to…
Read more >New customer trends: we rely on influencers and social media
Not only are social platforms playing a bigger role than…
Read more >Related news
The 2024 vintage wines performed excellently at the XXI. Synvino Wine Competition
A total of 400 entries were received from 18 wine…
Read more >What do corporate executives think about art?
Art is Business is organizing an event entitled “Top executives…
Read more >GELATISSIMO 2026: The largest professional meeting of the ice cream industry in Stuttgart
Ice cream lovers and industry representatives are eagerly awaiting the…
Read more >